| scholarly article | Q13442814 |
| P2093 | author name string | Dongqi Tang | |
| Dongming Su | |||
| Tongyun Liu | |||
| Chenfang Dong | |||
| Shiying Xuan | |||
| Zhenbo Dai | |||
| Xinhong Zhu | |||
| Weizheng Mao | |||
| Guiliang Ma | |||
| P2860 | cites work | NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors | Q35848615 |
| Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth | Q35921725 | ||
| Targeting tumors with LIGHT to generate metastasis-clearing immunity | Q37175025 | ||
| Adenovirus-mediated LIGHT gene modification in murine B-cell lymphoma elicits a potent antitumor effect | Q37729679 | ||
| CXC chemokine receptor 1 enhances the ability of human umbilical cord blood-derived mesenchymal stem cells to migrate toward gliomas | Q39570178 | ||
| Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma | Q39910399 | ||
| Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene | Q40141485 | ||
| Tumor vaccine based on cell surface expression of DcR3/TR6. | Q40437961 | ||
| Stored placental blood for unrelated bone marrow reconstitution | Q40708879 | ||
| Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway | Q40896166 | ||
| Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines. | Q41015040 | ||
| Approaches to utilize mesenchymal progenitor cells as cellular vehicles | Q44495575 | ||
| Comparison of the anti-tumor activity of native, secreted, and membrane-bound LIGHT in mouse tumor models | Q44508375 | ||
| CXCR4-transfected human umbilical cord blood-derived mesenchymal stem cells exhibit enhanced migratory capacity toward gliomas | Q45865276 | ||
| Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model | Q45875290 | ||
| Characterization and gene transfer in mesenchymal stem cells derived from human umbilical-cord blood | Q45887902 | ||
| Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas | Q48926056 | ||
| Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors | Q64378688 | ||
| LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response | Q73644490 | ||
| Mouse T cells receive costimulatory signals from LIGHT, a TNF family member | Q78385817 | ||
| Gastric cancer--new therapeutic options | Q79844903 | ||
| Re: Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents | Q81616464 | ||
| A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis | Q22009531 | ||
| LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator | Q24308657 | ||
| LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer | Q24564377 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| A TNF family member LIGHT transduces costimulatory signals into human T cells | Q28216861 | ||
| Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue | Q29620725 | ||
| Bone marrow stromal cells as targets for gene therapy | Q34729629 | ||
| CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma | Q35012653 | ||
| MMP-2 mediates mesenchymal stem cell tropism towards medulloblastoma tumors | Q35069593 | ||
| Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas | Q35827956 | ||
| P433 | issue | 2 | |
| P921 | main subject | gene therapy | Q213901 |
| human umbilical cord mesenchymal stem cell | Q107296600 | ||
| P304 | page(s) | 155-166 | |
| P577 | publication date | 2012-08-01 | |
| P1433 | published in | Gastric Cancer | Q15724608 |
| P1476 | title | Gene therapy of gastric cancer using LIGHT-secreting human umbilical cord blood-derived mesenchymal stem cells | |
| P478 | volume | 16 |
| Q38226664 | Cells as delivery vehicles for cancer therapeutics |
| Q94526850 | Efficacy of mesenchymal stem cells in the treatment of gastrointestinal malignancies |
| Q42391294 | Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse |
| Q98159785 | Evaluation of the expression of bone marrow-derived mesenchymal stem cells and cancer-associated fibroblasts in the stroma of gastric cancer tissue |
| Q27002840 | Gastric cancer stem cells: a novel therapeutic target |
| Q26853431 | Immunotherapeutic organoids: a new approach to cancer treatment |
| Q35549931 | Large-scale expansion of Wharton's jelly-derived mesenchymal stem cells on gelatin microbeads, with retention of self-renewal and multipotency characteristics and the capacity for enhancing skin wound healing |
| Q35159519 | Mesenchymal stem cells expressing interleukin-18 suppress breast cancer cells in vitro |
| Q38761193 | Opposite Effects of Coinjection and Distant Injection of Mesenchymal Stem Cells on Breast Tumor Cell Growth |
| Q26799123 | Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment |
| Q50594290 | VEGF Enhances the Migration of MSCs in Neural Differentiation by Regulating Focal Adhesion Turnover. |
| Q42368100 | pIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo |
Search more.